CBD targets have been suggested to play a role in cancer therapy resistance, including breast cancer resistance protein (ABCG2/BRCP) [24], bile salt export pump (ABCB11/BSEP) [11], and p-glycoprotein (p-gp) [25,26]. This evidence concerns the gene ABCB1 and cancer.